Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsWith over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsParticulate matter (PM), especially particulates with diameters of less than 2.5 mm, can penetrate the alveolar region and increase the risk of respiratory diseases. The proven adverse health effects of PM have stimulated various research efforts to develop methods for its detection. With years of research and development experience in phage display technology, Creative Biolabs has a group of scientists who are proficient in identifying binding-peptide with high specificity and affinity to particulate matter. We can provide the best service of identification of PM binding peptide at the most competitive cost.
The Introduction of PM
PM is a complex mixture of elemental and organic carbon, inorganic compounds such as sulfates and nitrates, as well as metal compounds. Both natural and manmade sources contribute to airborne PM. Typical detection methods include dynamic light scattering, gas chromatography-mass spectrometry, X-ray fluorescence and instrumental neutron activation. Although these methods are comprehensive, these methods suffer from the drawbacks of long processing time, decreased accuracy and the use of highly complex and expensive equipment. This has stimulated efforts to develop detection methods so that counter measures can be taken. Biomolecules are one of the solutions to the complex issues present in the aforementioned system. Among various biomolecules, peptides have relatively simple structures, making them easier to synthesize and more stable to environmental fluctuations. Furthermore, peptides can bind not only to biomolecules but also metal particulates. Researchers have found peptides capable of binding to metal particulates such as Ag, Au, and ZnO, making them promising candidates for PM detection.
Creative Biolabs has established the high-throughput phage display platform for phage display library screening against diverse targets. Our scientists have developed a new strategy for the identification of PM binding peptide. The process consists (1) coating of the PM, (2) incubation with premade phage display random peptide library, (3) washing the unbound peptides and bound peptides with low affinity, (4) elution and amplification of target binding peptide. After several rounds of biopanning, PM binding peptide could be selected and then binding characteristics will be further confirmed.
Key Advantages
Creative Biolabs has rich experience in phage display library screening against different PMs. We are confident in providing top-quality service to facilitate our clients’ related project development. Please feel free to inquire us for more information.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
